There's zero chance the trial will be complete by the EOY.
My guess is that the PMS P3 trail will have similar patient numbers to the Trofinetide trial, with around 200 participants.
That will take some time to recruit and complete. My guess is completion around mid 2027 with results at the end of 2027.
- Forums
- ASX - By Stock
- Ann: NEU confirms primary endpoints for Phase 3 trial in PMS
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.73%
!
$16.48

There's zero chance the trial will be complete by the EOY.My...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.48 |
Change
-0.290(1.73%) |
Mkt cap ! $2.076B |
Open | High | Low | Value | Volume |
$16.58 | $16.74 | $16.40 | $9.107M | 549.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 864 | $16.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.50 | 1668 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 864 | 16.430 |
1 | 2500 | 16.400 |
1 | 306 | 16.300 |
1 | 35 | 16.150 |
1 | 50 | 16.050 |
Price($) | Vol. | No. |
---|---|---|
16.620 | 58 | 1 |
16.720 | 100 | 1 |
16.750 | 300 | 1 |
16.890 | 1266 | 1 |
16.950 | 75 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online